Leap Therapeutics Inc. buy Rodman & Renshaw
Start price
28.06.24
/
50%
€1.64
Target price
28.06.25
€7.47
Performance (%)
-85.85%
End price
29.06.25
€0.23
Summary
This prediction ended on 29.06.25 with a price of €0.23. The BUY prediction by Rodman___Renshaw for Leap Therapeutics Inc. performed very badly with a performance of -85.85%. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | 12.534% | 12.534% | 144.379% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % |
Comments by Rodman___Renshaw for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
In the thread Trading Leap Therapeutics Inc.
Die von Rodman___Renshaw gewählte maximale Laufzeit wurde überschritten